Pliant Therapeutics, Inc.
NASDAQ:PLRX
12.62 (USD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 4.84 | 0 | 0.248 | 1.332 | 1.965 | 1.482 | 4.989 | 1.249 | 1.999 | 1.61 | 1.789 | 2.174 | 4.465 | 4.814 | 3.6 | 28.938 | 57.052 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0.622 | 0.513 | 0.464 | 1.045 | 1.104 | 1.061 | 1.053 | 1.03 | 0.899 | 0.699 | 2.087 | 0.4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| -0.622 | -0.513 | 4.376 | -1.045 | -0.856 | 0.271 | 0.912 | 0.452 | 4.09 | 0.55 | -0.088 | 1.21 | 1.789 | 2.174 | 4.465 | 4.814 | 3.6 | 28.938 | 57.052 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0.904 | 0 | -3.452 | 0.203 | 0.464 | 0.305 | 0.82 | 0.44 | -0.044 | 0.752 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 44.995 | 36.633 | 32.719 | 32.339 | 33.002 | 29.273 | 25.114 | 24.606 | 26.335 | 20.881 | 18.752 | 21.052 | 19.218 | 18.527 | 17.854 | 16.884 | 17.536 | 13.919 | 11.727 | 10.779 | 13.098 | 11.749 | 5.018 |
| General & Administrative Expenses
| 15.022 | 15.246 | 13.854 | 15.346 | 14.574 | 14.154 | 14.251 | 8.823 | 8.296 | 8.579 | 7.846 | 7.671 | 5.475 | 6.566 | 5.627 | 4.591 | 3.04 | 4.011 | 3.103 | 2.583 | 2.643 | 2.601 | 1.21 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 15.022 | 15.246 | 13.854 | 15.346 | 14.574 | 14.154 | 14.251 | 8.823 | 8.296 | 8.579 | 7.846 | 7.671 | 5.475 | 6.566 | 5.627 | 4.591 | 3.04 | 4.011 | 3.103 | 2.583 | 2.643 | 2.601 | 1.21 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.097 | 0.055 | -0.136 | -0.188 | -0.168 | -0.041 | -0.021 | 0.014 | 0 |
| Operating Expenses
| 60.017 | 51.879 | 46.573 | 47.685 | 47.576 | 43.427 | 39.365 | 33.429 | 34.631 | 29.46 | 26.598 | 28.723 | 24.693 | 25.093 | 23.481 | 21.475 | 20.576 | 17.93 | 14.83 | 13.362 | 15.741 | 14.35 | 6.238 |
| Operating Income
| -60.639 | -52.392 | -47.037 | -47.685 | -47.328 | -42.095 | -37.4 | -31.947 | -29.642 | -28.211 | -24.599 | -27.113 | -22.904 | -22.919 | -19.016 | -16.661 | -16.976 | 11.008 | 42.222 | -13.362 | -15.741 | -14.35 | -6.228 |
| Operating Income Ratio
| 0 | 0 | -9.718 | 0 | -190.839 | -31.603 | -19.033 | -21.557 | -5.941 | -22.587 | -12.306 | -16.84 | -12.803 | -10.542 | -4.259 | -3.461 | -4.716 | 0.38 | 0.74 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 4.785 | 5.437 | 5.928 | 6.198 | 6.136 | 4.547 | 2.34 | 1.332 | 0.096 | 0.111 | -0.272 | 0.068 | 0.073 | 0.063 | -0.097 | 0.055 | -0.136 | -0.188 | -0.168 | -0.041 | -0.021 | 0.014 | 0.006 |
| Income Before Tax
| -55.854 | -46.955 | -41.109 | -41.487 | -41.192 | -37.548 | -35.06 | -30.615 | -29.546 | -28.1 | -24.531 | -27.045 | -22.831 | -22.856 | -19.027 | -16.534 | -17.001 | 11.029 | 42.169 | -13.255 | -15.522 | -14.023 | -6.222 |
| Income Before Tax Ratio
| 0 | 0 | -8.494 | 0 | -166.097 | -28.189 | -17.842 | -20.658 | -5.922 | -22.498 | -12.272 | -16.798 | -12.762 | -10.513 | -4.261 | -3.435 | -4.723 | 0.381 | 0.739 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 0.47 | 3.398 | -0.448 | 6.455 | -9.405 | -0.455 | -2.664 | 0.269 | -0.222 | 0.272 | -0.012 | -0.03 | 0 | -0.433 | -0.402 | -0.111 | -0.209 | -0.115 | -0.148 | -0.24 | -0.313 | 0.882 |
| Net Income
| -55.854 | -46.955 | -41.109 | -41.487 | -41.192 | -28.143 | -34.605 | -27.951 | -29.546 | -27.878 | -24.531 | -27.045 | -22.831 | -22.856 | -19.027 | -16.534 | -17.001 | 11.029 | 40.022 | -13.255 | -15.522 | -14.023 | -7.104 |
| Net Income Ratio
| 0 | 0 | -8.494 | 0 | -166.097 | -21.128 | -17.611 | -18.86 | -5.922 | -22.32 | -12.272 | -16.798 | -12.762 | -10.513 | -4.261 | -3.435 | -4.723 | 0.381 | 0.702 | 0 | 0 | 0 | 0 |
| EPS
| -0.92 | -0.78 | -0.69 | -0.7 | -0.7 | -0.5 | -0.71 | -0.6 | -0.82 | -0.77 | -0.68 | -0.75 | -0.64 | -0.64 | -0.54 | -0.47 | -1.39 | 0.51 | 1.93 | -0.61 | -0.71 | -0.64 | -6.88 |
| EPS Diluted
| -0.92 | -0.78 | -0.69 | -0.7 | -0.7 | -0.5 | -0.71 | -0.6 | -0.82 | -0.77 | -0.68 | -0.75 | -0.64 | -0.64 | -0.54 | -0.47 | -1.39 | 0.48 | 1.93 | -0.58 | -0.68 | -0.61 | -6.88 |
| EBITDA
| -60.017 | -51.879 | -46.573 | -47.685 | -40.396 | -36.785 | -34.743 | -31.493 | -28.914 | -27.756 | -24.599 | -26.725 | -22.534 | -22.56 | -19.016 | -16.661 | -16.655 | 11.32 | 42.512 | -13.075 | -15.461 | -14.094 | -6.11 |
| EBITDA Ratio
| 0 | 0 | -9.623 | 0 | -162.887 | -27.616 | -17.681 | -21.25 | -5.796 | -22.223 | -12.306 | -16.599 | -12.596 | -10.377 | -4.259 | -3.461 | -4.626 | 0.391 | 0.745 | 0 | 0 | 0 | 0 |